David A. Tregouet
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.
Journal: Thrombosis and haemostasis
Published: July 14, 2026
Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B12.
Journal: Clinical epigenetics
Published: December 31, 2021
PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations.
Journal: Clinical epigenetics
Published: February 22, 2021
Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
Journal: Nature genetics
Published: June 05, 2019
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 01, 2019
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: September 20, 2018
A large-scale exome array analysis of venous thromboembolism.
Journal: Genetic epidemiology
Published: August 17, 2018
Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.
Journal: Human genetics
Published: May 21, 2018
Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients.
Journal: Nature communications
Published: February 04, 2018
Last Updated: 09/26/2026